R.H. Bluestein & Co’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-6,800
Closed -$952K 404
2020
Q3
$952K Sell
6,800
-9,100
-57% -$1.11M 0.05% 96
2020
Q2
$1.2M Buy
15,900
+700
+5% +$36.6K 0.07% 87
2020
Q1
$434K Buy
+15,200
New +$394K 0.04% 137

R.H. Bluestein & Co's LVGO Position: Q4 2020 in Review

R.H. Bluestein & Co sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 6,800 shares — an estimated $952K sold.

R.H. Bluestein & Co first reported a position in LVGO in Q1 2020 and held it in 3 quarters. The position peaked at $1.2M in Q2 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • R.H. Bluestein & Co reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • R.H. Bluestein & Co sold 6,800 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $952K.
  • R.H. Bluestein & Co first reported a position in Livongo Health, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • R.H. Bluestein & Co's Livongo Health, Inc. Common Stock position peaked at $1.2M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on R.H. Bluestein & Co's 13F filing for Q4 2020, filed 12 Feb 2021.